-
公开(公告)号:US4880802A
公开(公告)日:1989-11-14
申请号:US130373
申请日:1987-12-08
申请人: Rudolf Schohe , Thomas Glaser , Jorg Traber , George S. Allen
发明人: Rudolf Schohe , Thomas Glaser , Jorg Traber , George S. Allen
IPC分类号: C07C253/00 , A61K31/135 , A61K31/18 , A61K31/40 , A61K31/435 , A61K31/445 , A61K31/495 , C07C67/00 , C07C227/00 , C07C227/02 , C07C231/00 , C07C233/00 , C07C233/62 , C07C255/58 , C07C271/06 , C07C271/08 , C07C311/00 , C07C311/02 , C07C311/37 , C07C313/00 , C07C317/00 , C07C317/04 , C07C317/14 , C07D209/14 , C07D209/16 , C07D209/44 , C07D209/48 , C07D209/50 , C07D211/26 , C07D211/58 , C07D211/88 , C07D213/82 , C07D275/02 , C07D275/06 , C07D279/02 , C07D285/14 , C07D295/096 , C07D295/10 , C07D453/02 , C07D471/10 , C07D521/00
CPC分类号: C07D209/48 , C07C233/62 , C07C255/00 , C07D209/14 , C07D209/16 , C07D209/44 , C07D211/26 , C07D211/58 , C07D211/88 , C07D213/82 , C07D275/02 , C07D275/06 , C07D279/02 , C07D285/14 , C07D295/096 , C07D453/02 , C07D471/10 , C07C2103/74
摘要: For treatment of disorders of the central nervous system, the cardiovascular system or the intestinal tract, the new substituted basic 2-aminotetralins of the formula ##STR1## in which R.sup.1 represents hydrogen or alkyl,R.sup.2 represents hydrogen, alkyl or acyl, andR.sup.3 represents quinuclidine or a group of the formula --(CH.sub.2).sub.a --R.sup.4, --CH.sub.2 --CH.dbd.CH--(CH.sub.2).sub.b --R.sup.4, --CH.sub.2 --C.tbd.(CH.sub.2).sub.b --R.sup.4, ##STR2## wherein a denotes a number from 1 to 10,b denotes a number 0, 1, 2, 3 or 4,d denotes a number 2 or 3, andX denotes oxygen, sulphur, or NR.sup.5,and their salts.
摘要翻译: 为了治疗中枢神经系统,心血管系统或肠道疾病,新的取代的碱式2-氨基鸟嘌呤,其中R1代表氢或烷基,R2代表氢,烷基或酰基,R3代表式 奎宁环或式 - (CH 2)a -R 4,-CH 2 -CH = CH-(CH 2)b -R 4,-CH 2 -C 3(CH 2)b -R 4,其中a表示 1至10,b表示数字0,1,2,3或4,d表示数字2或3,X表示氧,硫或NR 5及其盐。
-
公开(公告)号:US4870085A
公开(公告)日:1989-09-26
申请号:US175066
申请日:1988-03-30
申请人: Thomas Glaser , Siegfried Raddatz , Jorg Traber , Allen, George
发明人: Thomas Glaser , Siegfried Raddatz , Jorg Traber , Allen, George
IPC分类号: A61K31/40 , A61K31/4427 , A61K31/445 , A61P9/06 , A61P9/10 , A61P25/20 , A61P43/00 , C07D209/16 , C07D401/06 , C07D403/06
CPC分类号: C07D401/06 , C07D209/16
摘要: Novel tryptamines of the formula ##STR1## in which X is an alkylene chain or 2 to 4 carbon atoms wherein a carbon atom may be replaced by O or N-lower alkyl, and wherein a carbon atoms may be substituted by lower alkyl,R is hydrogen, lower alkyl, lower alkoxy, phenyl-lower alkyl, phenyl-lower alkoxy, hydroxy, amino-lower alkyl, fluorine, chlorine, bromine, cyano, carbamoyl or azido,R.sup.1, R.sup.2, R.sup.3 and R.sup.4 each independently is hydrogen or lower alkyl,R.sup.5 is hydrogen, R.sup.6 --CO-- or R.sup.6 --SO.sub.2 --, andR.sup.6 is amino, lower alkoxy, phenyl or lower alkyl-phenyl,or dimers or salts thereof, are effective in treating disorders of the central nervous system.
摘要翻译: 其中X是亚烷基链或2至4个碳原子的式(IMAGE)的新型色胺,其中碳原子可被O或N-低级烷基取代,并且其中碳原子可以被低级烷基取代,R是 氢,低级烷基,低级烷氧基,苯基 - 低级烷基,苯基 - 低级烷氧基,羟基,氨基 - 低级烷基,氟,氯,溴,氰基,氨基甲酰基或叠氮基,R1,R2,R3和R4各自独立地为氢或低级 烷基,R5是氢,R6-CO-或R6-SO2-,R6是氨基,低级烷氧基,苯基或低级烷基 - 苯基,或其二聚体或其盐在治疗中枢神经系统疾病中是有效的。
-
公开(公告)号:US5155128A
公开(公告)日:1992-10-13
申请号:US714470
申请日:1991-06-13
IPC分类号: C07D275/06 , A61K31/00 , A61K31/38 , A61K31/40 , A61K31/425 , A61K31/428 , A61K31/435 , A61K31/4427 , A61K31/4465 , A61K31/45 , A61K31/451 , A61K31/495 , A61K31/50 , A61K31/505 , A61K31/54 , A61K45/00 , A61P9/00 , C07D211/40 , C07D221/20 , C07D401/00 , C07D417/12 , C07D471/08 , C07D487/08
摘要: A method of treating cerebral apoplexy in a patient in need thereof which comprises administering to said patient an amount effective therefor of a serotonin agonist which has a binding strength of less than 10,000 nmol/l on binding to 5HT.sub.1A receptors.
摘要翻译: 一种在有需要的患者中治疗脑中风的方法,其包括向所述患者施用对5HT1A受体结合时具有小于10,000nmol / l的结合强度的5-羟色胺激动剂的量。
-
公开(公告)号:US4988700A
公开(公告)日:1991-01-29
申请号:US407161
申请日:1989-09-14
IPC分类号: C07D275/06 , A61K31/00 , A61K31/38 , A61K31/40 , A61K31/425 , A61K31/428 , A61K31/435 , A61K31/4427 , A61K31/4465 , A61K31/45 , A61K31/451 , A61K31/495 , A61K31/50 , A61K31/505 , A61K31/54 , A61K45/00 , A61P9/00 , C07D211/40 , C07D221/20 , C07D401/00 , C07D417/12 , C07D471/08 , C07D487/08
摘要: A method of treating cerebral apoplexy in a patient in need thereof which comprises administering to said patient an amount effective therefor of a serotonin agonist which has a binding strength of less than 10,000 nmol/l on binding to 5HT.sub.1A receptors.
摘要翻译: 一种在有需要的患者中治疗脑中风的方法,其包括向所述患者施用对5HT1A受体结合时具有小于10,000nmol / l的结合强度的5-羟色胺激动剂的量。
-
公开(公告)号:US4647560A
公开(公告)日:1987-03-03
申请号:US763746
申请日:1985-08-08
IPC分类号: A61K31/55 , A61P25/28 , C07D471/10 , C07D487/04 , C07D487/10 , C07D243/24
CPC分类号: C07D471/10 , C07D487/10
摘要: The present invention relates to novel benzodiazepines, acid addition salts thereof, processes for their preparation and their use in combating diseases, in particular for the treatment of cerebral disorders caused by old age and for the treatment of disorders in learning and memory and amnesia.
摘要翻译: 本发明涉及新的苯二氮卓类,其酸加成盐,它们的制备方法及其在抗疾病中的用途,特别是用于治疗由老年引起的脑障碍和用于治疗学习和记忆障碍和遗忘症的障碍。
-
公开(公告)号:US5438144A
公开(公告)日:1995-08-01
申请号:US90224
申请日:1993-07-09
申请人: Jorg Traber , Willem H. Gispen
发明人: Jorg Traber , Willem H. Gispen
IPC分类号: A61K31/44 , C07D211/22
CPC分类号: A61K31/44
摘要: The invention relates to the use of 1,4-dihydropyridines having calcium antagonistic action, in particular of nimodipine, for the preparation of medicaments for controlling damage to peripheral nerves which is caused by diabetes.
摘要翻译: 本发明涉及具有钙拮抗作用的1,4-二氢吡啶的用途,特别是尼莫地平,用于制备用于控制由糖尿病引起的对周围神经的损害的药物。
-
27.
公开(公告)号:US4895848A
公开(公告)日:1990-01-23
申请号:US227962
申请日:1988-08-03
申请人: Jorg Traber , Klaus Opitz
发明人: Jorg Traber , Klaus Opitz
IPC分类号: A61K31/505 , A61P25/30 , C07D401/12 , C07D417/12
CPC分类号: A61K31/505
摘要: A method for the treatment of alcoholism and medicaments used for such treatment wherein patients receive an effective amount of a 2-pyrimidinyl-1-piperazine derivative of the formula ##STR1## in which n represents one of the numbers 2, 3, 4, 5 or 6, andR represents ##STR2## in which R.sup.1, R.sup.2 and R.sup.3 each independently denote hydrogen or lower alkyl, or salts thereof.
摘要翻译: 用于治疗酒精中毒和用于这种治疗的药物的方法,其中患者接受有效量的式“IMAGE”的2-嘧啶基-1-哌嗪衍生物,其中n表示数字2,3,4,5中的一个 或6,并且R表示其中R 1,R 2和R 3各自独立地表示氢或低级烷基或其盐的“IMAGE”。
-
公开(公告)号:US5200410A
公开(公告)日:1993-04-06
申请号:US884488
申请日:1992-05-15
摘要: A method of treating cerebral apoplexy in a patient in need thereof which comprises administering to said patient an amount effective therefor of a serotonin agonist which has a binding strength of less than 10,000 nmol/l on binding to 5HT.sub.1A receptors.
摘要翻译: 一种在有需要的患者中治疗脑中风的方法,其包括向所述患者施用对5HT1A受体结合时具有小于10,000nmol / l的结合强度的5-羟色胺激动剂的量。
-
公开(公告)号:US5070102A
公开(公告)日:1991-12-03
申请号:US579414
申请日:1990-09-10
IPC分类号: C07D275/06 , A61K31/00 , A61K31/38 , A61K31/40 , A61K31/425 , A61K31/428 , A61K31/435 , A61K31/4427 , A61K31/4465 , A61K31/45 , A61K31/451 , A61K31/495 , A61K31/50 , A61K31/505 , A61K31/54 , A61K45/00 , A61P9/00 , C07D211/40 , C07D221/20 , C07D401/00 , C07D417/12 , C07D471/08 , C07D487/08
摘要: A method of treating cerebral apoplexy in a patient in need thereof which comprises administering to said patient a amount effective therefor of a serotonin agonist which has an binding strength of less than 10,000 nmol/l on binding to 5HT.sub.1A receptors.
-
30.
公开(公告)号:US4918076A
公开(公告)日:1990-04-17
申请号:US314345
申请日:1989-02-22
申请人: Klaus Opitz , Jorg Traber
发明人: Klaus Opitz , Jorg Traber
IPC分类号: C07D211/90 , A61K31/00 , A61K31/44 , A61K31/445 , A61K31/451 , A61K31/455 , A61P3/14 , A61P25/30 , A61P25/32
CPC分类号: A61K31/44
摘要: A method of treating a patient afflicted with alcohol addiction which comprises administering to such patient an amount effective therefor of a dihydropyridine of the formula ##STR1## in which R.sup.1 is one or two substituents independently selected from the group consisting of nitro, halogen, trifluoromethyl and OCHF.sub.2,R.sup.2 and R.sup.3 each independently is alkyl with 1 to 12 carbon atoms optionally substituted by alkoxy with 1 to 4 C atoms, hydroxyl, halogen or N-methyl-N-benzylamino, andR.sup.4 is cyano or alkyl with 1 to 4 carbon atoms optionally substituted by hydroxyl or halogen.
摘要翻译: 一种治疗患有酒精成瘾症的患者的方法,其包括向所述患者施用有效量的下式的二氢吡啶的量:其中R 1是一个或两个独立地选自硝基,卤素,三氟甲基和 OCHF2,R2和R3各自独立地为具有1至12个碳原子的烷基,任选被具有1-4个C原子的烷氧基取代,羟基,卤素或N-甲基-N-苄基氨基,R4是氰基或具有1至4个碳原子的烷基 任选被羟基或卤素取代。
-
-
-
-
-
-
-
-
-